Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Minority Interest (2025)

Orchestra BioMed Holdings (OBIO) has disclosed Minority Interest for 1 consecutive years, with $9.8 million as the latest value for Q4 2025.

  • Quarterly Minority Interest changed N/A to $9.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $9.8 million for FY2025, N/A changed from the prior year.
  • Minority Interest for Q4 2025 was $9.8 million at Orchestra BioMed Holdings.
  • The five-year high for Minority Interest was $9.8 million in Q4 2025, with the low at $9.8 million in Q4 2025.